DrugPatentWatch Database Preview

Litigation Details for AVENTIS PHARMACEUTIC v. TEVA PHARMACEUTICALS (D.N.J. )

« Back to Dashboard

AVENTIS PHARMACEUTIC v. TEVA PHARMACEUTICALS (D.N.J. )

Docket		Date Filed
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To
Jury Demand		Referred To
Patents	4,254,129; 5,578,610; 5,855,912; 5,932,247; 6,037,353; 6,039,974; 6,113,942; 6,187,791; 6,399,632
Link to Docket	External link to docket

Details for AVENTIS PHARMACEUTIC v. TEVA PHARMACEUTICALS (D.N.J. )

Date Filed	Document No.	Description	Snippet	Link To Document
2006-01-30	143		to the Carr patent, U.S. Patent No. 4,254,129 (filed Apr. 10, 1979) (the “’129 patent”), which discloses…Carr et al. [U.S. Pat. No. 4,254,129, issued Mar. 3, 1981].” ’353 Patent, col.2 ll.31-35. The identity…infringement of U.S. Patent No. 6,037,353 (filed Mar. 2, 1995) (the “’353 patent”), U.S. Patent No. 6,187,791…the “’791 patent”), and U.S. Patent No. 6,399,632 (filed Sept. 15, 2000) (the “’632 patent”) (collectively…7 of U.S. Patent No. 5,750,703 (filed Feb. 2, 1995) (the “’703 patent” or “process patent”). On September	External link to document
2005-06-03	69		of U.S. Patent Nos. 5,738,872 (“the ’872 patent”), 6,113,942 (“the ’942 patent”), 5,855,912 (“the ’912…’912 patent”), 5,932,247 (“the ’247 patent”), and 6,039,974 (“the ’974 patent”) which disclose solid…non-infringement of the ’942 patent, the ’912 patent, and the ’247 patent. Aventis Pharms., Inc. v. Barr…872 patent are anticipated by prior art references U.S. Patent Nos. 4,929,605 (“the ’605 patent”), 4,996,061…,061 (“the ’061 patent”), 6,037,353 (“the ’353 patent”), 5,375,693 (“the ’693 patent”), and 4,254,129	External link to document